The effect of global 11╬▓-hydroxysteroid dehydrogenase type 1 deletion on renal function

Physiology 2014 (London, UK) (2014) Proc Physiol Soc 31, PCB106

Poster Communications: The effect of global 11╬▓-hydroxysteroid dehydrogenase type 1 deletion on renal function

T. Christensen1,2, R. W. Hunter1, B. L. Jensen2, M. A. Bailey1

1. University/British Heart Foundation Centre for Cardiovascular Science, The University of Edinburgh, Edinburgh, United Kingdom. 2. Department of Cardiovascular and Renal Research, The University of Southern Denmark, Odense, Denmark.

View other abstracts by:


INTRODUCTION. Glucocorticoid (GC) excess causes hypertension and cardiovascular disease (1). Renal mineralocorticoid and glucocorticoid receptors (MR & GR) regulate Na+ excretion and thence blood pressure (BP). The renin-angiotensinogen-aldosterone system (RAAS) activates MR, while the hypothalamic-pituitary-adrenal axis activates GR. However, these systems are not separate entities; signal crosstalk may occur at several stages including at receptor level (2). Renal GR & MR activity is tuned by intra-renal 11β-Hydroxysteroid Dehydrogenases (11βHSDs), which modulate GC concentrations. The kidney expresses both 11βHSD isoforms. While 11βHSD type 2 (inactivation of cortisol) has an established role as the protector distal nephron aldosterone sensitivity, the function of renal 11βHSD type 1 (reactivation of cortisol) is unknown (3). This study explores the effect of 11βHSD1 deletion on renal function. We hypothesise that 11βHSD1 promotes GC activity and anti-natriuresis thereby supporting BP (2). METHODS. All studies were conducted in age-matched male C57BL/6J mice: wild-type (WT) or global 11βHSD1 knockout (HSD1-/-). Mice were housed in metabolism cages (N=22) and fed 0.2% Na+ diet for 4 days and 2.1% Na+ diet for 8 days. Data were normalised, tested for normality, analysed by ANOVA and presented as F- and p-values of genotype (GT), salt intake (SI) and interaction (IA), respectively. Urinary steroid excretion (N=6) was analysed by ELISA (4). Plasma RAAS-parameters (N≥26) were measured by RIA (5).RESULTS. There was no difference in Na+ intake between HSD1-/- and WT mice (IA: F=1.66, p=ns; GT: F=0.74, p=ns). Genotype did not affect water balance (IA: F=1.49, p=ns; GT F=0.01, p=ns) or Na+ balance (IA: F=0.66, p=ns; GT F=0.25, p=ns). High Na+ diet increased corticosterone excretion 3-fold, but there were no differences between GTs (IA F=1.14, p=ns; GT F=0.10 p=ns; SI F=3.47, p<0.05). HSD1-/- mice had a 2.5-fold greater excretion of deoxycorticosterone (DOC) during high Na+ intake (IA F=3.00, p<0.05; GT F=4.40 p=ns; SI F=10.74, p<0.001). Plasma renin and angiotensinogen (AGT) concentrations were appropriately down regulated by high Na+ intake in both GTs (Renin: IA F=1.45, p=ns; GT F=1.36 p=ns; SI F=23.39, p<0.001) (AGT: IA F=0.19, p=ns; GT F=1.59, p=ns; SI F=6.09, p<0.05). The urinary excretion of nitric oxide metabolites (N=6) increased 80% during high Na+ intake with no difference between GTs (IA F=0.69, p=ns; GT F=0.06, p=ns; SI F=14.50, p<0.001). SUMMARY. Steroid (i.e. DOC) homeostasis was disrupted in HSD1-/- mice, but there was no significant effect on renal water/Na+ excretion. We hypothesise that such an effect may be masked by counter-regulatory changes in the neurohormonal controllers of Na+ excretion. Our future work is directed at unravelling the underlying mechanisms.



Where applicable, experiments conform with Society ethical requirements.

Site search

Filter

Content Type